Yuanbo Medical Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Later Stage VC
- Investors
-
6
Yuanbo Medical General Information
Description
Developer of human and veterinary biological products designed for disease prevention and diagnosis. The company leverages its proprietary rod-shaped virus and insect cell antigen expression platforms, as well as a structural immunoadjuvant vaccine design platform, enabling the development of pet-related vaccines, therapeutic biological products, and pathogen testing, providing solutions that enhance animal health and safety.
Contact Information
Corporate Office
- Room 401, Building C5
- No. 11 Kaiyuan Avenue, Huangpu District
- Guangzhou, Guangdong 510530
- China
Corporate Office
- Room 401, Building C5
- No. 11 Kaiyuan Avenue, Huangpu District
- Guangzhou, Guangdong 510530
- China
Yuanbo Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 25-Jun-2025 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 15-Jun-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 05-Aug-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 12-Jun-2019 | Completed | Generating Revenue | |||
| 1. Seed Round | 03-Jan-2018 | Completed | Startup |
Yuanbo Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Yuanbo Medical Patents
Yuanbo Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026000722-A1 | Canine α interferon mutant and use thereof | Pending | 26-Jun-2024 | ||
| WO-2024046312-A1 | Recombinant protein and the use thereof in preparation of respiratory syncytial virus vaccine | Inactive | 01-Sep-2022 |
Yuanbo Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Yuanbo Medical Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Tianjin Yiyi Hygiene Products | Corporation | Minority | ||
| Chobe Capital | Venture Capital | Minority | ||
| Redhill Capital | Growth/Expansion | Minority | ||
| Dawu Venture Capital | Venture Capital | Minority | ||
| Guangzhou Yuexiu Industrial Investment Fund Management | PE/Buyout | Minority |
Yuanbo Medical FAQs
-
When was Yuanbo Medical founded?
Yuanbo Medical was founded in 2017.
-
Where is Yuanbo Medical headquartered?
Yuanbo Medical is headquartered in Guangzhou, China.
-
What is the size of Yuanbo Medical?
Yuanbo Medical has 7 total employees.
-
What industry is Yuanbo Medical in?
Yuanbo Medical’s primary industry is Pharmaceuticals.
-
Is Yuanbo Medical a private or public company?
Yuanbo Medical is a Private company.
-
What is Yuanbo Medical’s current revenue?
The current revenue for Yuanbo Medical is .
-
Who are Yuanbo Medical’s investors?
Tianjin Yiyi Hygiene Products, Chobe Capital, Redhill Capital, Dawu Venture Capital, and Guangzhou Yuexiu Industrial Investment Fund Management are 5 of 6 investors who have invested in Yuanbo Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
